Kindred Healthcare, Inc. (KND) Tops Q2 EPS by 2c; Guides Q3, FY11
Get Alerts KND Hot Sheet
Join SI Premium – FREE
Kindred Healthcare, Inc. (NYSE: KND) reported Q2 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $1.29 billion versus the consensus estimate of $1.25 billion.
Sees Q3 2011 EPS of $0.25-$0.30, versus the consensus of $0.23.
Sees FY2011 EPS of $1.80-$1.90, versus the consensus of $1.80. Sees FY2011 revenue of $5.6 billion, versus the consensus of $5.43 billion.
Sees FY12 EPS of $1.65-$1.85, vs. the consensus of $1.79.
Sees Q3 2011 EPS of $0.25-$0.30, versus the consensus of $0.23.
Sees FY2011 EPS of $1.80-$1.90, versus the consensus of $1.80. Sees FY2011 revenue of $5.6 billion, versus the consensus of $5.43 billion.
Sees FY12 EPS of $1.65-$1.85, vs. the consensus of $1.79.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- Rogers Communications (RCI) Tops Q3 EPS by 42c
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share